Disposable Capsule Nebulizer for Precise Medication Dosage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medication delivery systems face challenges in precise dosage control, user-friendliness, sterility maintenance, interchangeability, and non-invasive administration, particularly in treating opioid dependency and overdose, where rapid and adaptable solutions are needed.
Innovation Solution
A versatile capsule system with hermetically sealed pharmaceutical compositions containing active ingredients like naloxone, yohimbine, and albuterol, designed for aerosolized delivery, featuring precise dosage adjustment based on patient weight and adaptable administration routes, integrated with sensors and automated delivery for enhanced monitoring and control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If a mesh nebulizer is used to deliver medication, then the medication delivery efficiency and portability are improved, but the device cost increases and the mesh plate requires replacement due to blocking
Solution Approach 1:
The patent employs disposable capsules containing pre-measured medication doses. Each capsule is hermetically sealed and designed for single-use, eliminating the need for cleaning and maintenance of the nebulizer device. The capsule is inserted into the nebulizer, used once, then discarded, avoiding mesh plate blocking issues and reducing device complexity.
2Device complexity
If traditional inhalers are used, then the device structure is simple, but the dosage control precision and user technique requirements worsen
Solution Approach 1:
The patent incorporates pre-measured doses of medication into hermetically sealed capsules before use. Each capsule contains an exact predetermined amount of medication, eliminating the need for users to measure or coordinate their inhalation technique. The capsule is simply inserted into the nebulizer and activated, ensuring precise dosage delivery without requiring user skill.
3Reliability
If hermetically sealed capsules are used, then sterility and stability are improved, but the device complexity and manufacturing cost increase
Solution Approach 1:
The patent divides the medication delivery system into separate functional components: hermetically sealed capsules containing medication and a nebulizer device that atomizes the medication. The capsule can be manufactured, sealed, and stored independently to maintain sterility, while the nebulizer handles only the atomization function. This segmentation allows each component to be optimized independently.
4Measurement precision
If automated delivery systems are implemented, then dosage accuracy and monitoring are improved, but the device complexity and cost increase
Solution Approach 1:
The patent employs capsules with built-in sensors that automatically detect and communicate medication level information to the nebulizer device. The system self-monitors dosage delivery, tracks remaining medication, and provides feedback without requiring external monitoring equipment or complex automated control systems. The capsule essentially serves itself by providing embedded sensing capabilities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system ensures accurate and safe medication delivery, maintaining sterility and stability, and offers adaptable administration options, improving patient safety and treatment efficacy in both chronic and acute scenarios, including opioid dependency and overdose management.
Implementation Method 1
activating an atomizer to atomize the liquid formulation and generate a plurality of atomized particles
Implementation Method 2
a first one-way valve in fluid communication with the resilient air bladder configured to allow fresh air to enter the resilient air bladder
Implementation Method 3
a second one-way valve in fluid communication the resilient air bladder and the tubular chamber. The second one-way valve is configured to force the atomized medication and the fresh air to move from the resilient air bladder to the tubular chamber
Data Source
AI summary
A pharmaceutical composition and method for treating opioid overdose, opioid dependency, and xylazine exposure is disclosed, utilizing an aqueous solution of sodium chloride. This solution contains active ingredients such as naloxone and yohimbine in specific concentrations, with naloxone targeting opioid overdose and yohimbine aimed at counteracting xylazine effects. In various embodiments, additional components like tolazoline and different buffers can be included. The disclosure introduces a unique delivery system that features a capsule with a vibrating mesh atomizer for efficient administration. Specifically, for yohimbine, a dual-reservoir capsule design facilitates controlled mixing with diluents or buffers. The administration of this pharmaceutical composition can be achieved through multiple methods, including intramuscular, intravenous, and atomized routes. The atomizing device incorporates a removable cap and a resilient air bladder, ensuring effective drug delivery. This system offers precision and adaptability in treating conditions related to opioid overdose, dependency, and xylazine exposure.